ROIVANT SCIENCES LTD.
ROIVANT SCIENCES LTD. (ROIV) has a dated narrative snapshot, but its priced-in model claim is temporarily suppressed because the model-solve record is unavailable or has changed.
421 institutional managers reported holding ROIV in 13F filings for the quarter ended 2026-03-31. Together they hold about 76% of the company; the top 10 hold 46%. 77 opened new positions that quarter. Held by FMR (Fidelity), Morgan Stanley, BlackRock, among others. On the short side, 33.2M shares were sold short as of the 2026-06-15 count, about 5% of shares outstanding (7.5 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
ROIV's share count grew 7.2% over the past five years even with $1.50B spent on repurchases. It pays no dividend. Cash returned over the past three years: $1.50B in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
Open-market insider buys at ROIV over the trailing three years: 2025: 1 buy totaling $50k. 13 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
ROIV's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-08-15 | -5.3% | -7.2% |
| 2023-11-14 | +5.7% | +16.5% |
| 2024-02-14 | +4.3% | -7.8% |
| 2024-05-31 | -3.5% | +1.3% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
ROIV's latest 8-K filings: 2026-08-06 (items 2.02, 9.01); 2026-05-20 (items 2.02, 9.01); 2026-04-02 (items 2.02, 7.01, 9.01); 2026-03-03 (items 1.01, 7.01, 8.01, 9.01); 2026-03-03 (items 7.01, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: June 28, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.